RecruitingNot Applicable

Traumatic Hemothorax Drainage and Daily Lavage

United States20 participantsStarted 2025-03-03

Plain-language summary

This HTX treatment study evaluates the effects of chest tube size and the benefits of daily irrigations on acute HTX. 20 acutely injured but stable trauma patients requiring a chest tube for HTX will be enrolled. Patients will be assigned a 28Fr or 14 Fr chest tube with serial lavage and drainage. The endpoints will be HTX volume (by CT scan), complications, additional interventions, hospital length of stay, chest tube duration, provider feedback, and patient-reported outcomes.

Who can participate

Age range15 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Able to provide consent for the research study
✓. More than 15 years of age
✓. Presence of acute traumatic HTX or HTX-PTX diagnosed on chest CT scan within 24 hours of injury and clinical indication for drainage (hemothorax of moderate or large size greater then 300 mL)
✓. Hemodynamic stability (heart rate 120 beats per minute; systolic blood pressure 90 mmHg)
✓. Bilateral or unilateral hemothorax of greater than 300 mL HTX by Mergo Formula from chest CT
✓. Able to complete the entire study including randomization, tube placement, lavages and final CT Scan.

Exclusion criteria

✕. Less than 15 years of Age
✕. Prisoner
✕. Pregnant due to the risk of CT scans
✕. HTX or HTX-PTX not requiring drainage or drainage performed prior to randomization/enrollment
✕. Patients undergoing operative intervention (i.e. thoracotomy) as initial management of hemothorax (6) Persistent hemodynamic instability after initial resuscitation and CT imaging

What they're measuring

Remaining Hemothorax Volume at 72 hours

Timeframe: 72 hours

Trial details

NCT IDNCT06937450

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-08-01

Contact for this trial

Jeremy W Cannon, MD

215-66-27320 jeremy.cannon@pennmedicine.upenn.edu

View on ClinicalTrials.gov More Hemothorax; Traumatic trials